Related Experiment Video
Updated: Apr 28, 2026

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Molecular biology of brain metastasis
Konstantina A Svokos1, Bodour Salhia2, Steven A Toms3
1Department of Neurosurgery, Pennsylvania College of Osteopathic Medicine, 4170 City Ave. Office of Graduate Medical Education, Philadelphia, PA 19131, USA. konstantina.svokos@gmail.com.
Abstract:
Metastasis to the central nervous system (CNS) remains a major cause of morbidity and mortality in patients with systemic cancer. As the length of survival in patients with systemic cancer improves, thanks to multimodality therapies, focusing on metastases to the CNS becomes of paramount importance. Unique interactions between the brain's micro-environment, blood-brain barrier, and tumor cells are hypothesized to promote distinct molecular features in CNS metastases that may require tailored therapeutic approaches. This review will focus on the pathophysiology, epigenetics, and immunobiology of brain metastases in order to understand the metastatic cascade. Cancer cells escape the primary tumor, intravasate into blood vessels, survive the hematogenous dissemination to the CNS, arrest in brain capillaries, extravasate, proliferate, and develop angiogenic abilities to establish metastases. Molecular biology, genetics, and epigenetics are rapidly expanding, enabling us to advance our knowledge of the underlying mechanisms involved. Research approaches using cell lines that preferentially metastasize in vivo to the brain and in vitro tissue-based studies unfold new molecular leads into the disease. It is important to identify and understand the molecular pathways of the metastatic cascade in order to target the investigation and development of more effective therapies and research directions.
Insights
Brain metastases are a major cause of death in cancer patients. Understanding the molecular pathways of cancer spread to the brain is key to developing targeted therapies.
Area of Science:
- Oncology
- Neuroscience
- Cancer Biology
Background:
- Central nervous system (CNS) metastases significantly impact cancer patient morbidity and mortality.
- Improving survival rates necessitate a focus on brain metastases and their unique biological characteristics.
- The brain micro-environment, blood-brain barrier, and tumor cell interactions create distinct molecular features in CNS metastases.
Purpose of the Study:
- To review the pathophysiology, epigenetics, and immunobiology of brain metastases.
- To elucidate the molecular mechanisms underlying the metastatic cascade to the CNS.
- To identify therapeutic targets for improved treatment strategies.
Main Methods:
- Review of existing literature on brain metastasis.
- Analysis of the metastatic cascade: primary tumor escape, intravasation, survival, arrest, extravasation, proliferation, and angiogenesis.
- Integration of molecular biology, genetics, and epigenetics findings.
- Consideration of research using in vivo and in vitro models.
Main Results:
- The metastatic cascade involves a complex series of steps from primary tumor to CNS colonization.
- Unique molecular features arise from interactions within the brain's micro-environment.
- Advances in molecular biology and genetics are revealing key pathways involved in brain metastasis.
Conclusions:
- Understanding the molecular pathways of the metastatic cascade is crucial for effective treatment.
- Tailored therapeutic approaches are likely required for CNS metastases.
- Further research into the molecular biology of brain metastasis will guide the development of novel therapies.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

